Physician

Muhammad Saad Ali Khan, M.D.

According to 2025 Medicare claims, Muhammad Khan, M.D. (NPI: 1669727590) practices internal medicine in the Champaign-Urbana, IL market, with the plurality of this provider's patient population coming from Champaign, IL. This provider's primary affiliated billing organization is CHRISTIE CLINIC, PLLC (NPI: 1871523829; TIN: 370802668) and primary practice location at 61820-3909. Khan is affiliated with the Stratum Med ACO (ACO ID: A4527) and Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 726 traditional Medicare patients, billed 179,763 HCPCS/CPT codes, and received $2,793,061 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 175 prescription claims across 66 beneficiaries totaling $160,680 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 44 claims. Open Payments data shows 42 records totaling $11,127. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,229 to $2,793,061. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,265 and ending at $160,680. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	12	12	$1,229
2017	116	220	$14,032
2018	405	30,341	$262,113
2019	805	200,904	$1,598,114
2020	802	164,257	$2,304,756
2021	573	156,809	$2,588,739
2022	658	171,836	$3,098,288
2023	805	204,934	$2,903,126
2024	726	179,763	$2,793,061

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	76	$3,265
2016	19	57	$2,372
2017	51	104	$35,756
2018	52	97	$102,581
2019	91	327	$251,722
2020	100	396	$695,166
2021	32	63	$11,540
2022	53	115	$106,119
2023	64	141	$57,875
2024	66	175	$160,680

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	44	$1,129
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	348	561	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	398	745	$13
80053	Blood test, comprehensive group of blood chemicals	107	317	$10
96372	Injection of drug or substance under skin or into muscle	124	250	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	129	381	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	46	2,260	$44,191
Letrozole	Letrozole	13	1,110	$305

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$829	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$10,298	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Muhammad Saad Ali Khan, M.D.?

Tedicare shows public-source Medicare data for Muhammad Saad Ali Khan, M.D. (NPI 1669727590), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Saad Ali Khan, M.D. have ACO affiliation data?

Muhammad Saad Ali Khan, M.D. is shown with ACO affiliation data for Stratum Med ACO (MSSP, ACO ID A4527) and Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Muhammad Saad Ali Khan, M.D.?

Muhammad Saad Ali Khan, M.D. is linked to CHRISTIE CLINIC, PLLC (billing NPI 1871523829) in the available physician profile data.

Does Muhammad Saad Ali Khan, M.D. have Open Payments data?

Muhammad Saad Ali Khan, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.